Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.

Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.

Item
http://www.wikidata.org/entity/Q33375956
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapyImiglucerase and its use for the treatment of Gaucher's diseaseAn overview on bone manifestations in Gaucher disease.Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher Disease.The European Gaucher Alliance: a survey of member patient organisations' activities, healthcare environments and concerns.Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1Bilateral Femoral Osteolytic Lesions in a Patient with Type 3 Gaucher Disease.Did the temporary shortage in supply of imiglucerase have clinical consequences? Retrospective observational study on 34 italian Gaucher type I patients.Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose - response relationships.Effects of imiglucerase on the growth and metabolism of Gaucher disease type I patients: a systematic review.Gaucher disease and bone manifestations.Long-term treatment outcomes in Gaucher disease.Skeletal involvement in Gaucher disease: An observational multicenter study of prognostic factors in the Argentine Gaucher disease patients.Oral health of a child being treated for subtype I Gaucher's disease.
P2860

Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.

Item
http://www.wikidata.org/entity/Q33375956
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical consequences of inter ...... n with type 1 Gaucher disease.
@ast
Clinical consequences of inter ...... n with type 1 Gaucher disease.
@en
type
label
Clinical consequences of inter ...... n with type 1 Gaucher disease.
@ast
Clinical consequences of inter ...... n with type 1 Gaucher disease.
@en
prefLabel
Clinical consequences of inter ...... n with type 1 Gaucher disease.
@ast
Clinical consequences of inter ...... n with type 1 Gaucher disease.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Clinical consequences of inter ...... n with type 1 Gaucher disease.
@en
P2093
P304
P31
P356
10.1016/J.JPEDS.2007.02.057
P407
P433
P478
P577
P5875
P698
P921